HCM ▲ +0.6% - HUTCHMED (China) Limited $HCM - HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine 25-OCT-2026 08:00 PM ET